Valuation Novartis AG Mexican S.E.

Stocks

End-of-day quote Mexican S.E. 25/09/2026			5-day change	1st Jan Change
2,572.00 ^MXN	+5.24%		+5.24%	+2.88%

10:24pm	Merck's experimental skin disease drug succeeds in mid-stage study	RE
10:20pm	Major drugmakers turn to China for licensing deals	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	196,458	194,448	207,167	195,514	266,003	275,257	-	-
Change	-	-1.02%	6.54%	-5.62%	36.05%	3.48%	-	-
Enterprise Value (EV) ¹	204,649	203,482	219,178	213,458	289,870	306,689	303,517	296,847
Change	-	-0.57%	7.71%	-2.61%	35.8%	5.8%	-1.03%	-2.2%
P/E	8.2x	28.3x	14.1x	16.5x	19.2x	20.5x	17.2x	14.9x
PBR	2.9x	3.23x	4.41x	4.52x	5.73x	5.81x	5.44x	4.93x
PEG	-	-0.4x	0x	-1x	0.9x	-9.82x	0.9x	1x
Capitalization / Revenue	3.81x	3.85x	4.44x	3.78x	4.69x	4.77x	4.48x	4.21x
EV / Revenue	3.96x	4.03x	4.7x	4.13x	5.11x	5.32x	4.94x	4.54x
EV / EBITDA	11.2x	10.9x	12.2x	10.2x	12.4x	13.2x	12x	10.9x
EV / EBIT	12.3x	12.2x	13.4x	10.9x	13.2x	14.1x	12.8x	11.6x
EV / FCF	15.4x	17x	16.6x	13.1x	16.5x	19.7x	17.9x	15.5x
FCF Yield	6.49%	5.87%	6.01%	7.61%	6.07%	5.07%	5.58%	6.44%
Dividend per Share ²	3.36	3.5	3.823	3.856	4.762	4.35	4.542	4.774
Rate of return	3.83%	3.87%	3.79%	3.94%	3.44%	3%	3.14%	3.3%
EPS ²	10.71	3.19	7.15	5.92	7.21	7.06	8.436	9.731
Distribution rate	31.4%	110%	53.5%	65.1%	66%	61.6%	53.8%	49.1%
Net sales ¹	51,626	50,545	46,660	51,722	56,674	57,668	61,426	65,343
EBITDA ¹	18,246	18,613	17,937	21,006	23,415	23,295	25,291	27,265
EBIT ¹	16,588	16,665	16,372	19,494	21,889	21,811	23,642	25,568
Net income ¹	24,021	6,955	14,854	11,939	13,967	14,209	15,782	17,621
Net Debt ¹	8,191	9,034	12,011	17,944	23,867	31,432	28,259	21,590
Reference price ²	87.82	90.40	100.79	97.79	138.63	144.82	144.82	144.82
Nbr of stocks (in thousands)	2,237,092	2,150,980	2,055,460	1,999,270	1,918,792	1,900,715	-	-
Announcement Date	2/2/22	1/2/23	31/1/24	31/1/25	4/2/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	33.68x	12.2x	24.79x	0.59%	1,056B
JOHNSON & JOHNSON	29.76x	6.61x	18.5x	2%	645B
ABBVIE INC.	33.32x	7.79x	16.11x	2.63%	465B
MERCK & CO., INC.	108.6x	6.05x	25.67x	2.29%	368B
ROCHE HOLDING AG	19.01x	4.64x	11.49x	2.87%	335B
NOVARTIS AG	20.51x	5.32x	13.17x	3.01%	275B
ASTRAZENECA PLC	20.92x	4.34x	12.36x	2.04%	255B
AMGEN INC.	26.76x	6.95x	12.37x	2.38%	229B
GILEAD SCIENCES, INC.	-45.76x	6.66x	26x	2.18%	188B
Average	27.42x	6.73x	17.83x	2.22%	423.98B
Weighted average by Cap.	32.80x	7.85x	19.23x	1.9%